The correlation between cT2 stage, cT3 stage, and ER+HER2− subtype with higher odds of a positive SLN after NST is supported by previous research.27–29 Both clinical tumor size and tumor subtype are independent predictors of pathologic complete response (pCR). Here, ESR1 is linked to neoplasm.